NCT00524511

Brief Summary

Women who have a cesarean delivery have a surgical incision on their abdomen (belly). The usual way to close this opening is with metal surgical staples. In many other types of surgery, surgical incisions are closed with a super-glue called Dermabond. The researchers at the University of Massachusetts believe Dermabond may be a safe alternative to using staples at the time of a cesarean delivery, but this has not been studied. Women who choose to participate will be randomly assigned to have the cesarean delivery skin incision closed with staples or Dermabond. The researchers will survey the patients to see how they felt about the experience and the appearance of their scar. The researchers will survey physicians performing the surgery to see how easy Dermabond was to use. The researchers will ask physicians to evaluate the appearance of the incision after a 6-week recovery period and will analyze complications (such as bruising, infection, or separation of the wound) in the two groups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2007

Completed
1 day until next milestone

Study Start

First participant enrolled

September 1, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 3, 2007

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
10 months until next milestone

Results Posted

Study results publicly available

March 5, 2013

Completed
Last Updated

March 5, 2013

Status Verified

January 1, 2013

Enrollment Period

4.7 years

First QC Date

August 31, 2007

Results QC Date

October 24, 2012

Last Update Submit

January 24, 2013

Conditions

Keywords

cesareanwoundDermabondsupergluestapleswound complications

Outcome Measures

Primary Outcomes (1)

  • Wound Complication Rate

    Wound seroma or hematoma, wound separation, wound requiring packing, cellulitis, required extra medical clinic visits to evaluate wound

    within six weeks of study intervention

Secondary Outcomes (1)

  • Patient Satisfaction of Cosmesis of Surgical Wound

    before hospital discharge after surgery

Study Arms (2)

1

EXPERIMENTAL

Women receiving Dermabond for skin closure

Device: Surgical skin staples

2

ACTIVE COMPARATOR

Women receiving standard surgical skin staples

Device: Dermabond

Interventions

Standard method to close abdominal surgical wounds

1
DermabondDEVICE

Alternative method (superglue) to close abdominal surgical wounds

Also known as: Tissue adhesive
2

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women undergoing scheduled and non-scheduled cesarean deliveries

You may not qualify if:

  • Prisoners
  • Insulin-requiring diabetics
  • Vertical skin incision
  • Allergy to Dermabond

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMass Memorial Medical Center

Worcester, Massachusetts, 01604, United States

Location

MeSH Terms

Conditions

Wounds and Injuries

Interventions

Tissue Adhesives

Intervention Hierarchy (Ancestors)

Biomedical and Dental MaterialsSpecialty Uses of ChemicalsChemical Actions and UsesSurgical Fixation DevicesSurgical EquipmentEquipment and SuppliesManufactured MaterialsTechnology, Industry, and Agriculture

Results Point of Contact

Title
Dawn Tasillo, MD
Organization
UMass Memorial Medical Center

Study Officials

  • Dawn S Tasillo, MD

    University of Massachusetts, Worcester

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 31, 2007

First Posted

September 3, 2007

Study Start

September 1, 2007

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

March 5, 2013

Results First Posted

March 5, 2013

Record last verified: 2013-01

Locations